These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2170496)

  • 1. [LH-RH agonists. Fundamental aspects].
    Leroy-Billiard M; Longelin C
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(5):582-6. PubMed ID: 2170496
    [No Abstract]   [Full Text] [Related]  

  • 2. Extra pituitary actions of LHRH analogues in tissues of the human female and investigation of the existence and function of LHRH-like peptides.
    Fraser HM; Bramley TA; Miller WR; Sharpe RM
    Prog Clin Biol Res; 1986; 225():29-54. PubMed ID: 3024178
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacologic suppression of the ovarian function and its clinical usefulness].
    Kershenovich Sefchovich R; Kably Ambe A; García Morales MA; Peryra Quiñones R; Barrón Vallejo J
    Ginecol Obstet Mex; 1997 Aug; 65():344-8. PubMed ID: 9324471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Response of gonadotropic hormones and ovarian steroids to various LH-RH agonists. A comparative study].
    Bringer J; Hedon B; Bouhaddioui L; Audran F; Orsetti A; Sultan C
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(5):586-7. PubMed ID: 2212516
    [No Abstract]   [Full Text] [Related]  

  • 5. [GnRH agonists. New possibility for treatment of hormone-dependent gynecologic diseases].
    Bergqvist A; Bergquist C
    Lakartidningen; 1993 Mar; 90(12):1155-8, 1163. PubMed ID: 8385729
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of different LH-RH agonists on the levels of immunoreactive gonadotropins.
    Insler V; Lunenfeld E; Potashnik G; Levy J
    Gynecol Endocrinol; 1988 Dec; 2(4):305-12. PubMed ID: 2976572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception with LHRH agonists, a new physiological approach.
    Labrie F; Séguin C; Bélanger A; Lefebvre FA; Massicotte J; Kelly PA; Pelletier G; Reeves JJ; Lemay A; Cusan L; Raynaud JP
    Reproduccion; 1981; 5(4):229-41. PubMed ID: 6274723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cessation of progesterone secretion by LH-RH in hypophysectomized pregnant and hypophysectomized, prolactin injected pseudopregnant rats.
    Macdonald GJ; Greeley LK; Beattie CW
    Int J Fertil; 1980; 25(3):198-202. PubMed ID: 6108930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and experimental basis of therapy with LHRH agonists in women.
    Sandow J; Fraser HM; Geisthövel F
    Prog Clin Biol Res; 1986; 225():1-27. PubMed ID: 3024177
    [No Abstract]   [Full Text] [Related]  

  • 12. LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
    Szepeshazi K; Schally AV; Halmos G
    Int J Oncol; 2007 Jun; 30(6):1485-92. PubMed ID: 17487370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GnRH antagonists. Therapeutic and practical aspects].
    Bouchard P
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(5):607-8. PubMed ID: 2170497
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular aspects of the inhibitory actions of LH-RH on the ovary and testis.
    Sharpe RM
    J Reprod Fertil; 1982 Mar; 64(2):517-27. PubMed ID: 6279835
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sites of paradoxical action of the LHRH agonist (D-Trp6)-LHRH.
    Arimura A; Talbot S; Serafini PC; Schally AV
    Int J Fertil; 1980; 25(3):151-6. PubMed ID: 6108923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
    Krebs LJ; Wang X; Pudavar HE; Bergey EJ; Schally AV; Nagy A; Prasad PN; Liebow C
    Cancer Res; 2000 Aug; 60(15):4194-9. PubMed ID: 10945629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies on gonadotropin-releasing hormone in teleosts, amphibians, reptiles and mammals.
    Peter RE
    Prog Clin Biol Res; 1986; 205():75-93. PubMed ID: 3006082
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.